These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8777167)

  • 21. Immunohistochemical localization of Bcl-2 and Bax proteins in in situ and invasive duct breast carcinomas.
    Kapucuoglu N; Losi L; Eusebi V
    Virchows Arch; 1997 Jan; 430(1):17-22. PubMed ID: 9037310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of apoptosis regulators in breast cancer.
    Krajewski S; Krajewska M; Turner BC; Pratt C; Howard B; Zapata JM; Frenkel V; Robertson S; Ionov Y; Yamamoto H; Perucho M; Takayama S; Reed JC
    Endocr Relat Cancer; 1999 Mar; 6(1):29-40. PubMed ID: 10732784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland.
    Branet F; Brousset P; Krajewski S; Schlaifer D; Selves J; Reed JC; Caron P
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2726-30. PubMed ID: 8675602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.
    Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM
    Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas.
    Bukholm IK; Nesland JM
    Virchows Arch; 2000 Mar; 436(3):224-8. PubMed ID: 10782880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome.
    Peiró G; Diebold J; Baretton GB; Kimmig R; Löhrs U
    Int J Gynecol Pathol; 2001 Oct; 20(4):359-67. PubMed ID: 11603220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired BAX protein expression in breast cancer: mutational analysis of the BAX and the p53 gene.
    Sturm I; Papadopoulos S; Hillebrand T; Benter T; Lück HJ; Wolff G; Dörken B; Daniel PT
    Int J Cancer; 2000 Aug; 87(4):517-21. PubMed ID: 10918191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
    Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlations of HER-2, PCNA, Bcl-2, and Bax expression to prognosis of breast cancer].
    Yang L; Zhu X; Ran L
    Ai Zheng; 2007 Jul; 26(7):756-61. PubMed ID: 17626754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.
    Bargou RC; Wagener C; Bommert K; Mapara MY; Daniel PT; Arnold W; Dietel M; Guski H; Feller A; Royer HD; Dörken B
    J Clin Invest; 1996 Jun; 97(11):2651-9. PubMed ID: 8647960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas.
    Ogura E; Senzaki H; Yamamoto D; Yoshida R; Takada H; Hioki K; Tsubura A
    Oncol Rep; 1999; 6(2):365-9. PubMed ID: 10023006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.
    Raouf AA; Evoy DA; Carton E; Mulligan E; Griffin MM; Reynolds JV
    Dis Esophagus; 2003; 16(1):17-23. PubMed ID: 12581249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.
    Krajewski S; Krajewska M; Ehrmann J; Sikorska M; Lach B; Chatten J; Reed JC
    Am J Pathol; 1997 Mar; 150(3):805-14. PubMed ID: 9060818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma.
    de Vicente JC; Olay S; Lequerica-Fernandez P; Sánchez-Mayoral J; Junquera LM; Fresno MF
    J Oral Pathol Med; 2006 Mar; 35(3):140-5. PubMed ID: 16454809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix.
    Soufla G; Baritaki S; Sifakis S; Zafiropoulos A; Spandidos DA
    Int J Biol Markers; 2005; 20(1):18-27. PubMed ID: 15832769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study.
    Sirvent JJ; Aguilar MC; Olona M; Pelegrí A; Blázquez S; Gutiérrez C
    Histol Histopathol; 2004 Jul; 19(3):759-70. PubMed ID: 15168338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma.
    Sierra A; Lloveras B; Castellsagué X; Moreno L; García-Ramirez M; Fabra A
    Int J Cancer; 1995 Jan; 60(1):54-60. PubMed ID: 7814152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of Bax and Bcl-2 in the assessment of cellular dynamics in fine-needle samples of primary breast carcinomas.
    Maciorowski Z; Klijanienko J; Padoy E; Mosseri V; Diéras V; El-Naggar AK; Chevillard S; Vielh P
    Cytometry; 2000 Oct; 42(5):264-9. PubMed ID: 11025483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
    Krajewska M; Krajewski S; Epstein JI; Shabaik A; Sauvageot J; Song K; Kitada S; Reed JC
    Am J Pathol; 1996 May; 148(5):1567-76. PubMed ID: 8623925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.